Geoffrey B. Johnson, MD, PhD, presented “Appropriate Use of PSMA PET in Clinical Practice” during the 33rd International Prostate Cancer Update on January 24, 2023, in Vail, Colorado.

How to cite: Johnson, Geoffrey B. “Appropriate Use of PSMA PET in Clinical Practice.” January 24, 2023. Accessed Mar 2024. https://grandroundsinurology.com/appropriate-use-of-psma-pet-in-clinical-practice-2/

Appropriate Use of PSMA PET in Clinical Practice – Summary

Geoffrey B. Johnson, MD, PhD, delivers an informative presentation on the appropriate utilization of PSMA PET in clinical practice, delving into various aspects of this advanced imaging technique. Dr. Johnson begins by elucidating the diverse range of prostate cancer PET radiotracers available, with a particular focus on the recently FDA-approved PSMA imaging agents. 

In addition to discussing the different types of PET radiotracers, Dr. Johnson also delves into the complex landscape of reimbursement criteria for PSMA PET. Drawing comparisons to traditional imaging methods, he highlights the advantages of PSMA PET in terms of its ability to detect prostate cancer metastases more accurately, paving the way for enhanced diagnostic accuracy and improved treatment decision-making.

 

About The 33rd Annual International Prostate Cancer Update:

The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. The 33rd iteration of the meeting occurred January 22-25, 2023 in Vail, Colorado. To view more educational presentations from IPCU 33, visit our collection page.